8M0

bis(mu4-oxo)-tetrakis(mu3-oxo)-hexakis(mu2-oxo)-hexadecaoxo-octamolybdenum (VI)

Created:	2012-06-28
Last modified:	2020-06-05

Find Related PDB Entry
13 entries where 8M0 is found as a standalone ligand1 entries where 8M0 is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	-8
Atom Count	36
Chiral Atom Count	0
Bond Count	48
Aromatic Bond Count	0

2D diagram of 8M0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	bis(mu4-oxo)-tetrakis(mu3-oxo)-hexakis(mu2-oxo)-hexadecaoxo-octamolybdenum (VI)
Formula	Mo₈ O₂₈
Molecular Weight	1,215.503
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	[O-][Mo]\|123(=O)O[Mo]\|45([O-])(=O)O[Mo]678([O-])O\|1[Mo]([O-])(=O)(=O)(O2)\|O6[Mo]9%10([O-])(=O)O[Mo]%11%12([O-])(O\|4[Mo]\|%13([O-])(=O)(=O)O[Mo]([O-])(=O)(O%11\|%13)(O9)[O]7%10%12)[O]358
SMILES	OpenEye OEToolkits	1.7.6	[O-][Mo]12(=O)(=O)O[Mo]34(=O)(O1[Mo]567(O2[Mo]89(=O)(O51[Mo]2(=O)(O8)(O[Mo]5(=O)(=O)(O2[Mo]11(O36[Mo](=O)(O51)(O4)(O7)[O-])(O9)[O-])[O-])[O-])[O-])[O-])[O-]
Canonical SMILES	CACTVS	3.385	[O-][Mo]\|123(=O)O[Mo]\|45([O-])(=O)O[Mo]678([O-])O\|1[Mo]([O-])(=O)(=O)(O2)\|O6[Mo]9%10([O-])(=O)O[Mo]%11%12([O-])(O\|4[Mo]\|%13([O-])(=O)(=O)O[Mo]([O-])(=O)(O%11\|%13)(O9)[O]7%10%12)[O]358
Canonical SMILES	OpenEye OEToolkits	1.7.6	[O-][Mo]12(=O)(=O)O[Mo]34(=O)([O@@]1[Mo]567([O@]2[Mo]89(=O)(O51[Mo]2(=O)(O8)(O[Mo]5(=O)(=O)([O@@]2[Mo]11(O36[Mo](=O)([O@]51)(O4)(O7)[O-])(O9)[O-])[O-])[O-])[O-])[O-])[O-]
InChI	InChI	1.03	InChI=1S/8Mo.28O/q;;;;;;;;;;;;;;;;;;;;;;;;;;;;8*-1
InChIKey	InChI	1.03	GSOSAILZTJNYOK-UHFFFAOYSA-N

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.